SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-17-000002
Filing Date
2017-01-23
Accepted
2017-01-23 16:30:32
Documents
3
Period of Report
2017-01-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20170117x8k.htm 8-K 35269
2 EX-99.1 bpmx-20170117ex99138a656.htm EX-99.1 9619
3 GRAPHIC bpmx20170117ex99138a656001.jpg GRAPHIC 7098
  Complete submission text file 0001504167-17-000002.txt   55948
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 17541342
SIC: 2834 Pharmaceutical Preparations